What adjuvant treatment would you recommend for stage III colon cancer in a patient >75yo but with a good performance status?
Since some prior subset analyses have suggested that oxaliplatin may not improve outcomes of older patients with colon cancer in the adjuvant setting, how do you approach this decision in older patients who are fit?
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Stanford University School of Medicine
Answered on
As is often the case, I'd have to say "it depends". If the patient had stage IIIA disease for which the survival curves are better than IIB and comparable to IIA patients, I'd be inclined to offer capecitabine alone (providing no other poor risk factors such as insufficient nodal count, poorly differentiated histology, angiolymphatic or perineural invasion). If stage IIIB or higher and if limited comorbidities (i.e. low competing cause of death such as cardiac or pulmonary conditions) and lack o...
Join for free or sign in to see the full answer